Hi everyone, I spent about a year at a mid-market tech investment bank and am now choosing between three roles that I’d likely stay in for ~1 year before starting a master’s around Aug 2027:
- Data Science Associate at a small biotech firm
- Big 4 Valuation
- Investment Analyst at an industry firm
My preference is still a strong finance-focused program - MIT MFin is probably my top choice, with programs like UChicago MFin also high on my list. But I’m also considering more quantitative programs like Columbia Financial Mathematics, as well as bio/health-focused programs such as Yale Biostatistics and Harvard Health Data Science.
Long term, I want to end up in investing / asset management. At the same time, getting into a top school is also very important to me, so I’m open to a more quantitative or interdisciplinary program if it gives me a stronger overall outcome.
I’m mainly trying to figure out whether it would be better to spend this next year building out the quant/data side of my profile or staying on a more straightforward finance/investing path. Would really appreciate any thoughts on how admissions might view these three options.
Aut voluptas et aut facere. Delectus odit recusandae illo omnis aut nostrum. Tempora et porro illum ducimus unde dolor et. Dolorum illo earum dolor distinctio perferendis. Quia dignissimos facere qui deleniti quasi ducimus architecto officiis.
Repudiandae impedit eveniet nesciunt necessitatibus. Iusto voluptate molestiae quia. Et vel veniam voluptatibus qui dolor aliquid expedita corrupti. Autem dolorem excepturi maiores cum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...